| 2025-06-26 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-3.81美元,归母净利润-32.93亿美元,同比去年增长41.52%
|
| 2025-06-26 |
财报披露：
美东时间 2025-06-26 盘前发布财报
|
| 2025-06-06 |
股东大会：
将于2025-07-11召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of March 6, 2025 (as it may be amended from time to time, the “Merger Agreement”), by and among the Company, Blazing Star Parent, LLC, a Delaware limited liability company (“Parent”), Blazing Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and the other affiliates of Parent named therein (collectively, together with Parent and Merger Sub, the “Parent Entities”), a copy of which is attached as Annex A to the accompanying proxy statement, pursuant to which, subject to the terms and conditions set forth therein and among other things, Merger Sub will be merged with and into the Company with the Company surviving such merger as a wholly owned subsidiary of Parent (the “Merger” and, collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”) (such proposal, the “Merger Agreement Proposal”);
2.To consider and vote on a proposal to adjourn the Special Meeting, from time to time, to a later date or dates if necessary or appropriate, including adjournments to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal (the “Adjournment Proposal”);
3.To consider and approve, by nonbinding, advisory vote, certain compensation arrangements for the Company’s named executive officers in connection with the Merger (the “Merger-Related Compensation Proposal”).
|
| 2025-06-06 |
详情>>
股本变动：
变动后总股本86556.07万股
|
| 2025-04-08 |
详情>>
业绩披露：
2025年中报每股收益-3.61美元,归母净利润-31.18亿美元,同比去年增长47.82%
|
| 2025-01-10 |
详情>>
业绩披露：
2025年一季报每股收益-0.31美元,归母净利润-2.65亿美元,同比去年增长-295.52%
|
| 2024-12-13 |
股东大会：
将于2025-01-30召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 12 director nominees named in this Proxy Statement
2.Approve, on an advisory basis, our named executive officer compensation
3.Approve the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan
4.Approve the Amended and Restated Walgreens Boots Alliance, Inc. Employee Stock Purchase Plan
5.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2025
6.Approve an amendment to the Amended and Restated Certificate of Incorporation to provide for officer exculpation
7.Consider one stockholder proposal, if properly presented at the meeting
|
| 2024-10-15 |
详情>>
业绩披露：
2024年年报每股收益-10.01美元,归母净利润-86.36亿美元,同比去年增长-180.39%
|
| 2024-10-15 |
详情>>
业绩披露：
2022年年报每股收益5.02美元,归母净利润43.37亿美元,同比去年增长70.61%
|
| 2024-06-27 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-6.53美元,归母净利润-56.31亿美元,同比去年增长-94.17%
|
| 2024-03-28 |
详情>>
业绩披露：
2023年中报每股收益-3.5美元,归母净利润-30.18亿美元,同比去年增长-167.62%
|
| 2024-03-28 |
详情>>
业绩披露：
2024年中报每股收益-6.93美元,归母净利润-59.75亿美元,同比去年增长-97.98%
|
| 2024-01-04 |
详情>>
业绩披露：
2024年一季报每股收益-0.08美元,归母净利润-6700万美元,同比去年增长98.20%
|
| 2023-12-08 |
股东大会：
将于2024-01-25召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 11 director nominees named in this Proxy Statement
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2024
3.Approve, on an advisory basis, our named executive officer compensation
4.Approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation
5.Consider five stockholder proposals, if properly presented at the meeting.
|
| 2023-10-12 |
详情>>
业绩披露：
2023年年报每股收益-3.57美元,归母净利润-30.8亿美元,同比去年增长-171.02%
|
| 2023-06-27 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.36美元,归母净利润-29亿美元,同比去年增长-161.03%
|
| 2022-12-08 |
股东大会：
将于2023-01-26召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 10 director nominees named in this Proxy Statement
2.Approve, on an advisory basis, our named executive officer compensation
3.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2023
4.Consider two stockholder proposals, if properly presented at the meeting
|
| 2021-12-08 |
股东大会：
将于2022-01-27召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 10 director nominees named in this Proxy Statement
2.Approve, on an advisory basis, our named executive officer compensation
3.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2022
4.Consider three stockholder proposals, if properly presented at the meeting
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-12-08 |
股东大会：
将于2021-01-28召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 11 director nominees named in this proxy statement;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2021;
3.Approve, on an advisory basis, our named executive officer compensation;
4.Approve the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan;
5.Consider two stockholder proposals, if properly presented at the meeting.
|
| 2019-12-10 |
股东大会：
将于2020-01-30召开股东大会
会议内容 ▼▲
- 1.Vote on the election of 10 director nominees named in this proxy statement
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2020
3.Approve, on an advisory basis, our named executive officer compensation
4.Consider three stockholder proposals, if properly presented at the meeting
|
| 2018-12-06 |
股东大会：
将于2019-01-25召开股东大会
会议内容 ▼▲
- 1.To vote on the election of 11 director nominees named in this proxy statement;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2019;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To approve the amended and restated Walgreens Boots Alliance, Inc. Employee Stock Purchase Plan;
5.To consider four stockholder proposals, if properly presented at the meeting;
6.To transact such other business as may properly come before the meeting or any adjournment thereof.
|
| 2017-11-29 |
股东大会：
将于2018-01-17召开股东大会
会议内容 ▼▲
- 1.To vote on the election of 11 director nominees named in this proxy statement;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending August 31, 2018;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation;
5.To approve the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan;
6.To consider two stockholder proposals, if properly presented at the meeting;
7.To transact such other business as may properly come before the meeting or any adjournment thereof.
|
| 2016-12-08 |
股东大会：
将于2017-01-26召开股东大会
会议内容 ▼▲
- 1.Elect the ten director nominees named in the proxy statement;
2.Approve, on an advisory basis, the Company’s named executive officer compensation;
3.Ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2017;
4.Approve the material terms of the performance measures under the Company’s 2011 Cash-Based Incentive Plan;
5.Vote on the two stockholder proposals contained in the proxy statement, if properly presented at the meeting;
6.Transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2015-12-09 |
股东大会：
将于2016-01-27召开股东大会
会议内容 ▼▲
- (1)To elect 11 directors to hold office until the next Annual Meeting of Stockholders or until their successors are elected and qualified;
(2)To approve, on an advisory basis, the compensation of the named executive officers;
(3)To ratify Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending August 31, 2016;
(4)To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2014-12-29 |
详情>>
内部人交易：
Gourlay Alexander W.共交易2笔
|
| 2014-10-08 |
除权日：
美东时间 2014-11-13 每股派息0.34美元
|
| 2014-08-05 |
除权日：
美东时间 2014-08-19 每股派息0.34美元
|
| 2014-04-09 |
除权日：
美东时间 2014-05-19 每股派息0.32美元
|
| 2014-01-09 |
除权日：
美东时间 2014-02-13 每股派息0.32美元
|
| 2013-10-09 |
除权日：
美东时间 2013-11-14 每股派息0.32美元
|
| 2013-07-10 |
除权日：
美东时间 2013-08-16 每股派息0.32美元
|
| 2013-04-10 |
除权日：
美东时间 2013-05-17 每股派息0.28美元
|
| 2013-01-10 |
除权日：
美东时间 2013-02-13 每股派息0.28美元
|
| 2012-10-10 |
除权日：
美东时间 2012-11-07 每股派息0.28美元
|
| 2012-06-19 |
除权日：
美东时间 2012-08-15 每股派息0.28美元
|
| 2012-04-09 |
除权日：
美东时间 2012-05-17 每股派息0.23美元
|
| 2012-01-12 |
除权日：
美东时间 2012-02-15 每股派息0.23美元
|
| 2011-10-12 |
除权日：
美东时间 2011-11-09 每股派息0.23美元
|
| 2011-07-13 |
除权日：
美东时间 2011-08-17 每股派息0.23美元
|
| 2011-04-11 |
除权日：
美东时间 2011-05-18 每股派息0.18美元
|
| 2011-01-13 |
除权日：
美东时间 2011-02-16 每股派息0.18美元
|
| 2010-10-13 |
除权日：
美东时间 2010-11-10 每股派息0.18美元
|
| 2010-07-14 |
除权日：
美东时间 2010-08-17 每股派息0.18美元
|